Unlike regular insulin, which must be administered about 15–30 min before meals, glulisine can be administered just before or even after eating, allowing greater schedule flexibility and adjusting the dose to the amount of carbohydrates ingested, which is especially useful in patients with T1D. The gene discussed is INS; the disease is type 1 diabetes mellitus.